Biguanides enhance antifungal activity against Candida glabrata

Candida spp. are the fourth leading cause of nosocomial blood stream infections in North America. Candida glabrata is the second most frequently isolated species, and rapid development of antifungal resistance has made treatment a challenge. In this study, we investigate the therapeutic potential of...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Shuying Xu, Marianela Feliu, Allison K. Lord, Daniel P. Lukason, Paige E. Negoro, Nida S. Khan, Zeina Dagher, Michael B. Feldman, Jennifer L. Reedy, Samantha N. Steiger, Jenny M. Tam, Alexander A. Soukas, David B. Sykes, Michael K. Mansour
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis Group 2018-12-01
Reeks:Virulence
Onderwerpen:
Candida
Candida glabrata
biguanide
drug resistance
metformin
minimum inhibitory concentration (MIC)
Online toegang:http://dx.doi.org/10.1080/21505594.2018.1475798
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items